NDC 50090-5915-01 - Atorvastatin calcium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-5915
- Requested NDC
- 50090-5915-01
- Package NDCs from labels
- 50090-5915-2, 50090-5915-1, 50090-5915-0, 50090-5915-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2023-11-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Atorvastatin calcium - A-S Medication Solutions | A-S Medication Solutions | 2023-11-24 | Human Prescription Drug Label |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-5915-0 | Atorvastatin calcium | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 3 | |
| 50090-5915-1 | Atorvastatin calcium | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | 3 | |
| 50090-5915-2 | Atorvastatin calcium | 100 in 1 BOTTLE | TABLET, FILM COATED | 100 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-5915 | ATORVASTATIN CALCIUM TABLET, FILM COATED [A-S MEDICATION SOLUTIONS] | 3 | Current NDC, Legacy NDC, 3 package rows | 20231125_d97df6ad-87ca-46ec-8de7-4a958ab3b463.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-5915-0 | EA - Each | 50090-5915 | 3c064c88-9b42-4d89-95c0-f23858442463 | 1 | 2022-06-06 |
| 50090-5915-1 | EA - Each | 50090-5915 | 518a3741-813f-426f-9a14-299ce0b72ae3 | 1 | 2022-06-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| HERA SILKYSTAY FOUNDATION 23C2 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb44e1b-b24b-6c83-e063-6394a90a4b52 | 2026-10-25 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 23W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb468db-3c38-922d-e063-6294a90adef8 | 2026-10-25 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 24N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb4b8ca-eced-b7ff-e063-6394a90aaefe | 2026-10-25 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 24O1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb4f87a-b4dc-1aa5-e063-6294a90a2ec4 | 2026-10-25 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 25W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb50784-444e-3bf3-e063-6294a90aa618 | 2026-10-25 | Warnings | 15FIX9V2JP |
| Tums Chewy Bites | CALCIUM CARBONATE | Select Consumer Group | 3caa037e-3424-f9ce-e063-6294a90ac1e8 | 2026-10-24 | Warnings | H0G9379FGK |
| Quality Choice Ultra Strength | ANTACID TABLET (CALCIUM CARBONATE) | QUALITY CHOICE (Chain drug Marketing Assoiciation) | cdac56f1-e579-4943-a24a-6564c30086d2 | 2026-10-23 | Warnings | H0G9379FGK |
| QUALITY CHOICE Regular Strength | ANTACID TABLETS (CALCIUM CARBONATE) | QUALITY CHOICE (Chain drug Marketing Assoiciation) | fce6c50d-908f-44a6-ba63-ece813f3711b | 2026-10-23 | Warnings | H0G9379FGK |
| QUALITY CHOICE Ultra Strength | ANTACID TABLETS (CALCIUM CARBONATE) | QUALITY CHOICE (Chain drug Marketing Assoiciation) | b074a885-5d10-46e4-8de9-dd9460968dad | 2026-10-23 | Warnings | H0G9379FGK |
| QUALITY CHOICE | CALCIUM CARBONATE | QUALITY CHOICE (Chain drug Marketing Assoiciation) | 9ff282fd-7623-4c9e-8faa-c51e33a7616e | 2026-10-23 | Warnings | H0G9379FGK |
| calcium antacidextra strength extra strength | CALCIUM CARBONATE | Rugby Laboratories | d761954f-940e-4833-87b7-173a921aade1 | 2026-10-23 | Warnings | H0G9379FGK |
| Rugby Cal-Gest Antacid Assorted Flavors | ANTACID TABLETS | Rugby Laboratories, Inc. | a43184c4-d225-4539-b651-4d96535f208f | 2026-10-23 | Warnings | H0G9379FGK |
| QUALITY CHOICE Regular Strength | ANTACID TABLETS (CALCIUM CARBONATE) | QUALITY CHOICE (Chain drug Marketing Assoiciation) | 667ffb59-9bff-45a7-89f0-ccfa0d841909 | 2026-10-23 | Warnings | H0G9379FGK |
| Atorvastatin calcium | ATORVASTATIN CALCIUM | Umedica Laboratories USA Inc. | 5a7594ca-30be-4350-827f-ef745a2a7e18 | 2026-10-23 | Warnings, Adverse reactions | 617311 617310 259255 617312 |
| Atorvastatin calcium | ATORVASTATIN CALCIUM | NIVAGEN PHARMACEUTICALS, INC. | 7c58bf4a-4a92-4db8-89bc-4de1b5831efc | 2026-10-23 | Warnings, Adverse reactions | 617311 617310 259255 617312 |
| Clear Eyes Triple Relief | POLYVINYL ALCOHOL AND POVIDONE AND TETRAHYDROZOLINE HYDROCHLORIDE | Prestige Brands Holdings, Inc. | 1269a1a6-843d-4d08-bb3c-c1f3d2e7080d | 2026-10-23 | Warnings | 532B59J990 |
| QUALITY CHOICE Extra Strength | ANTACID TABLETS (CALCIUM CARBONATE) | QUALITY CHOICE (Chain drug Marketing Assoiciation) | 7c948dc6-e569-46d2-8edd-59da48857e0e | 2026-10-23 | Warnings | H0G9379FGK |
| Rugby | ANTACID TABLETS | Rugby Laboratories | 9cb56bc3-7075-4f81-bd10-7e602034b7d8 | 2026-10-23 | Warnings | H0G9379FGK |
| PNV-Omega | ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL, PYRIDOXINE HYDROCHLORIDE, FOLIC ACID, CYANOCOBALAMIN, CALCIUM CORBONATE, FERROUS FUMARATE, POTASSIUM IODIDE, MAGNESIUM, DOCONEXENT, ICOSAPENT | Acella Pharmaceuticals, LLC | 735c5531-137f-4cee-8c68-ae121045a8ff | 2026-10-23 | Boxed warning, Adverse reactions | H0G9379FGK |
| Quality Choice Extra Strength | ANTACID TABLETS (CALCIUM CARBONATE) | QUALITY CHOICE (Chain drug Marketing Assoiciation) | 2bb8ccb6-6275-4ace-8096-ee545501df39 | 2026-10-23 | Warnings | H0G9379FGK |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.